Cited by 391Influenza Virus Research StudiesPneumonia and Respiratory InfectionsRespiratory viral infections research

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States.

Open access

Rice, Todd W., Rubinson, Lewis, Uyeki, Timothy M., Vaughn, Frances L., John, Benjamin B., Miller, Russell R., Higgs, Elizabeth, Randolph, Adrienne G., Smoot, B. Elizabeth, Thompson, B. Taylor·2012·Critical Care Medicine

DOI 10.1097/ccm.0b013e3182416f23PMC PMC3653183

Open this paper in CoChat — free account

Abstract

OBJECTIVES: The contribution of bacterial coinfection to critical illness associated with 2009 influenza A virus infection remains uncertain. The objective of this study was to determine whether bacterial coinfection increased the morbidity and mortality of 2009 influenza A. DESIGN: Retrospective and prospective cohort study. SETTING: Thirty-five adult U.S. intensive care units over the course of 1 yr. PATIENTS: Six hundred eighty-three critically ill adults with confirmed or probable 2009 influenza A. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A confirmed or probable case was defined as a positive 2009 influenza A test result or positive test for influenza A that was otherwise not subtyped. Bacterial coinfection was defined as documented bacteremia or any presumed bacterial pneumonia with or without positive respiratory tract culture within 72 hrs of intensive care unit admission. The mean age was 45±16 yrs, mean body mass index was 32.5±11.1 kg/m, and mean Acute Physiology and Chronic Health Examination II score was 21±9, with 76% having at least one comorbidity. Of 207 (30.3%) patients with bacterial coinfection on intensive care unit admission, 154 had positive cultures with Staphylococcus aureus (n=57) and Streptococcus pneumoniae (n=19), the most commonly identified pathogens. Bacterial coinfected patients were more likely to present with shock (21% vs. 10%; p=.0001), require mechanical ventilation at the time of intensive care unit admission (63% vs. 52%; p=.005), and have longer duration of intensive care unit care (median, 7 vs. 6 days; p=.05). Hospital mortality was 23%; 31% in bacterial coinfected patients and 21% in patients without coinfection (p=.002). Immunosuppression (relative risk 1.57; 95% confidence interval 1.20 -2.06; p=.0009) and Staphylococcus aureus at admission (relative risk 2.82; 95% confidence interval 1.76-4.51; p<.0001) were independently associated with increased mortality. CONCLUSIONS: Among intensive care unit patients with 2009 influenza A, bacterial coinfection diagnosed within 72 hrs of admission, especially with Staphylococcus aureus, was associated with significantly higher morbidity and mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1097/ccm.0b013e3182416f23

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,920
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
Liu, C., Bayer, A. S., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,260
Incidence and Outcomes of Acute Lung Injury
Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., & Hudson, L. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050333 · Cited by 3,684
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
Self-citation
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Higher vs Lower Positive End-Expiratory Pressure in Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome: Systematic Review and Meta-analysis
Briel, M., Meade, M., Mercat, A., Brower, R. G., Talmor, D., Walter, S. D., Slutsky, A. S., Pullenayegum, E., Zhou, Q., Cook, D., et al. (2010) · JAMA · doi:10.1001/jama.2010.218 · Cited by 1,467
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Ventilation Strategy Using Low Tidal Volumes, Recruitment Maneuvers, and High Positive End-Expiratory Pressure for Acute Lung Injury and Acute Respiratory Distress Syndrome: A Randomized Controlled Trial
Meade, M. O., Cook, D. J., Guyatt, G. H., Slutsky, A. S., Arabi, Y. M., Cooper, D. J., Davies, A. R., Hand, L. E., Zhou, Q., Thabane, L., et al. (2008) · JAMA · doi:10.1001/jama.299.6.637 · Cited by 1,370
Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico
Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quiñones-Falconi, F., Bautista, E., Ramirez-Venegas, A., Rojas-Serrano, J., Ormsby, C. E., Corrales, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904252 · Cited by 1,325

Show all 37 references

Research works printed but not linked: 1

Hanslik, 2010, PLoS Curr Influenza, 9, RRN1150

Sorted by citations

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
Langford, B. J., So, M., Raybardhan, S., Leung, V., Westwood, D. J., MacFadden, D. R., Soucy, J.-P. R., & Daneman, N. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.016 · Cited by 1,589
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
Alhazzani, W. A., Møller, M. H., Arabi, Y. M., Loeb, M. B., Gong, M. N., Fan, E., Oczkowski, S. J. W., Levy, M. M., Derde, L. P. G., Dzierba, A. L., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,578
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy866 · Cited by 844
Self-citation
The co-pathogenesis of influenza viruses with bacteria in the lung.
McCullers, J. A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3231 · Cited by 722
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting
Hughes, S., Troise, O., Donaldson, H., Mughal, N., & Moore, L. S. P. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.025 · Cited by 645
Secondary bacterial infections associated with influenza pandemics
Morris, D. E., Cleary, D. W., & Clarke, S. C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01041 · Cited by 576
Influenza virus-related critical illness: pathophysiology and epidemiology
Kalil, A. C., & Thomas, P. G. (2019) · Critical Care · doi:10.1186/s13054-019-2539-x · Cited by 524
Bacterial Coinfection in Influenza: A Grand Rounds Review
Chertow, D. S., & Memoli, M. J. (2013) · JAMA · doi:10.1001/jama.2012.194139 · Cited by 390
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU
Contou, D., Claudinon, A., Pajot, O., Micaëlo, M., Flandre, P. L., Dubert, M., Cally, R., Logre, E., Fraissé, M., Mentec, H., et al. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00736-x · Cited by 324
The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09.
MacIntyre, C. R., Chughtai, A. A., Barnes, M., Ridda, I., Seale, H., Toms, R., & Heywood, A. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3548-0 · Cited by 323
Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association
Cao, B., Huang, Y. X., She, D., Cheng, Q., Fan, H. S., Tian, X., Xu, J., Zhang, J., Chen, Y., Shen, N., et al. (2017) · The Clinical Respiratory Journal · doi:10.1111/crj.12674 · Cited by 309
The spleen and sickle cell disease: the sick(led) spleen
Brousse, V. A. M., Buffet, P. A., & Rees, D. C. (2014) · British Journal of Haematology · doi:10.1111/bjh.12950 · Cited by 291
Bacterial co‐infections with SARS‐CoV ‐2
Mirzaei, R., Goodarzi, P., Asadi, M., Soltani, A., Aljanabi, H. A. A., Jeda, A. S., Dashtbin, S., Jalalifar, S., Mohammadzadeh, R., Teimoori, A., et al. (2020) · IUBMB Life · doi:10.1002/iub.2356 · Cited by 306
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease
Rynda‐Apple, A., Robinson, K. M., & Alcorn, J. F. (2015) · Infection and Immunity · doi:10.1128/iai.00298-15 · Cited by 294
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
Liu, T., Luo, S., Libby, P., & Shi, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107587 · Cited by 276
Bacterial Coinfections in Coronavirus Disease 2019
Westblade, L. F., Simon, M. S., & Satlin, M. J. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.018 · Cited by 215
Increased incidence of co-infection in critically ill patients with influenza
Martín‐Loeches, I., Schultz, M. J., Vincent, J., Álvarez-Lerma, F., Bos, L. D. J., Solé‐Violán, J., Torres, A., & Rodríguez, A. H. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4578-y · Cited by 215
Influenza virus-related critical illness: prevention, diagnosis, treatment
Chow, E. J., Doyle, J., & Uyeki, T. M. (2019) · Critical Care · doi:10.1186/s13054-019-2491-9 · Cited by 208
Self-citation
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
Chong, W. H., Saha, B. K., Ramani, A., & Chopra, A. (2021) · Infection · doi:10.1007/s15010-021-01602-z · Cited by 174
Bacterial Complications of Respiratory Tract Viral Illness: A Comprehensive Evaluation
Falsey, A. R., Becker, K. L., Swinburne, A. J., Nylen, E. S., Formica, M. A., Hennessey, P. A., Criddle, M. M., Peterson, D. R., Baran, A., & Walsh, E. E. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit190 · Cited by 159
Treating influenza with statins and other immunomodulatory agents
Fedson, D. S. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.06.018 · Cited by 162
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia*
Cao, B., Gao, H., Zhou, B., Deng, X., Hu, C., Deng, C., Lu, H., Li, Y., Gan, J., Liu, J., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001616 · Cited by 157
Epidemic and pandemic viral infections: impact on tuberculosis and the lung
Ong, C. W. M., Migliori, G. B., Raviglione, M. C., Macgregor-Skinner, G., Sotgiu, G., Alffenaar, J. C., Tiberi, S., Adlhoch, C., Alonzi, T., Archuleta, S., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01727-2020 · Cited by 163
Co-infection in critically ill patients with COVID-19: an observational cohort study from England
Baskaran, V., Lawrence, H., Lansbury, L., Webb, K., Safavi, S., Zainudin, N. I., Huq, T., Eggleston, C., Ellis, J. P., Thakker, C. E., et al. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001350 · Cited by 147
A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918–1919
Nickol, M. E., & Kindrachuk, J. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3750-8 · Cited by 151
Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality
Beumer, M. C., Koch, R. M., Beuningen, D. V., Oudelashof, A. M., van de Veerdonk, F. L., Kolwijck, E., van der Hoeven, J. G., Bergmans, D. C. J. J., & Hoedemaekers, C. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.11.013 · Cited by 141
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis
Rodríguez, A. H., Avilés‐Jurado, F. X., Díaz, E., Schüetz, P., Trefler, S., Solé‐Violán, J., Cordero, L., Vidaur, L., Estella, Á., Pozo, J. C., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.11.007 · Cited by 136
The immunology of influenza virus-associated bacterial pneumonia.
Robinson, K. M., Kolls, J. K., & Alcorn, J. F. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.002 · Cited by 132
Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients
Liu, Y., Ling, L., Wong, S. H., Wang, M. H., Fitzgerald, J. R., Zou, X., Fang, S., Liu, X., Wang, X., Hu, W., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100955 · Cited by 133
Evaluation of the BioFire FilmArray Pneumonia Panel for Detection of Viral and Bacterial Pathogens in Lower Respiratory Tract Specimens in the Setting of a Tertiary Care Academic Medical Center
Webber, D. M., Wallace, M. A., Burnham, C. D., & Anderson, N. W. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00343-20 · Cited by 128
Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study
Karaba, S. M., Jones, G. F., Helsel, T., Smith, L., Avery, R. K., Dzintars, K., Salinas, A. B., Keller, S. C., Townsend, J., Klein, E. Y., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa578 · Cited by 127
In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection
Moorthy, A. N., Narasaraju, T., Rai, P., Perumalsamy, R., Tan, K. B., Wang, S., Engelward, B. P., & Chow, V. T. K. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00056 · Cited by 125
Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2
Manna, S., Baindara, P., & Mandal, S. M. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.07.003 · Cited by 115
Global Burden of Influenza as a Cause of Cardiopulmonary Morbidity and Mortality
Fischer, W. A., Gong, M. N., Bhagwanjee, S., & Sevransky, J. (2014) · Global Heart · doi:10.1016/j.gheart.2014.08.004 · Cited by 118
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany
Ludwig, M., Jacob, J., Basedow, F., Andersohn, F., & Walker, J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.11.204 · Cited by 113
Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013–14
Shah, N. S., Greenberg, J. A., McNulty, M., Gregg, K., Riddell, J., Mangino, J. E., Weber, D. M., Hebert, C. L., Marzec, N. S., Barron, M. A., et al. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.04.008 · Cited by 112
Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?
Pelfrene, E., Botgros, R., & Cavaleri, M. (2021) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-021-00893-z · Cited by 111
Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons
Oliva, J., & Terrier, O. (2021) · Viruses · doi:10.3390/v13091725 · Cited by 113
Covid-19 induced superimposed bacterial infection
Hendaus, M. A., & Jomha, F. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772110 · Cited by 113
Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis
Pfister, R., Kochanek, M., Leygeber, T., Brun‐Buisson, C., Cuquemelle, É., Machado, M. P., Piacentini, E. A., Hammond, N. E., Ingram, P. R., & Michels, G. (2014) · Critical Care · doi:10.1186/cc13760 · Cited by 105
Toxic Shock Syndrome
Low, D. E. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.03.012 · Cited by 104
Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease
Steel, H. C., Cockeran, R., Anderson, R., & Feldman, C. H. (2013) · Mediators of Inflammation · doi:10.1155/2013/490346 · Cited by 104
Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical Trial
Rouzé, A., Martín‐Loeches, I., Póvoa, P. M. S. R., Metzelard, M., du Cheyron, D., Lambiotte, F., Tamion, F., Labruyère, M., Geronimi, C. B., Nieszkowska, A., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202101-0030oc · Cited by 99
Impfen bei Immundefizienz
Niehues, T., Bogdan, C., Hecht, J., Mertens, T., Wiese‐Posselt, M., & Zepp, F. (2017) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-017-2555-4 · Cited by 97
Secondary Bacterial Infections in Critical Ill Patients With Coronavirus Disease 2019
Fu, Y., Yang, Q., Xu, M., Kong, H., Chen, H., Fu, Y., Yao, Y., Zhou, H., & Zhou, J. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa220 · Cited by 97
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt
Ramadan, H. K., Mahmoud, M. A., Aburahma, M. Z., Elkhawaga, A. A., El‐Mokhtar, M. A., Sayed, I. M., Hosni, A. M., Hassany, S. M., & Medhat, M. A. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s272605 · Cited by 113
Risk factors for bacterial infections in patients with moderate to severe COVID‐19: A case‐control study
Nasir, N., Rehman, F., & Omair, S. F. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27000 · Cited by 90
Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic
Burrell, A. J. C., Pellegrini, B., Salimi, F., Begum, H., Broadley, T., Campbell, L. T., Cheng, A. C., Cheung, W., Cooper, D. J., Earnest, A., et al. (2020) · The Medical Journal of Australia · doi:10.5694/mja2.50883 · Cited by 89
Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie
Laws, H.-J., Baumann, U., Bogdan, C., Burchard, G., Christopeit, M., Hecht, J., Heininger, U., Hilgendorf, I., Kern, W., Kling, K., et al. (2020) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-020-03123-w · Cited by 88
Viral Pneumonia and Acute Respiratory Distress Syndrome
Shah, R. D., & Wunderink, R. G. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.11.013 · Cited by 89
Staphylococcus aureus Pneumonia in the Community
He, H., & Wunderink, R. G. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1709992 · Cited by 92
Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review
Cong, W., Poudel, A. N., Alhusein, N., Wang, H., Yao, G., & Lambert, H. (2021) · Antibiotics · doi:10.3390/antibiotics10060745 · Cited by 85
Influenza
Uyeki, T. M. (2017) · Annals of Internal Medicine · doi:10.7326/aitc201709050 · Cited by 84
Self-citation
The Burden of Influenza-Associated Critical Illness Hospitalizations*
Ortiz, J. R., Neuzil, K. M., Shay, D. K., Rue, T. C., Neradilek, M. B., Zhou, H., Seymour, C. W., Hooper, L. G., Cheng, P., Goss, C. H., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000545 · Cited by 82
Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections
Ku, Y.-H., Chan, K., Yang, C.-C., Tan, C., Chuang, Y.-C., & Yu, W. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.06.002 · Cited by 82
The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles
Tarabichi, Y., Li, K., Hu, S., Nguyen, C., Wang, X., Elashoff, D., Saira, K., Frank, B., Bihan, M., Ghedin, E., et al. (2015) · Microbiome · doi:10.1186/s40168-015-0133-2 · Cited by 77
What is the Role of Respiratory Viruses in Community-Acquired Pneumonia?
Pavia, A. T. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2012.11.007 · Cited by 79
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia
Søgaard, K. K., Baettig, V., Osthoff, M. F., Marsch, S. C. U., Leuzinger, K., Schweitzer, M., Meier, J., Bassetti, S., Bingisser, R. M., Nickel, C. H., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00526-y · Cited by 77
Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes
Weiss, S. L., & Fitzgerald, J. C. (2023) · PEDIATRICS · doi:10.1542/peds.2023-062967 · Cited by 88
Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
Estrada, A. D. B., Calderón‐Parra, J., Carracedo, E. F., Míguez, A. M., Ramos, A., Múñez, E., Rubio‐Rivas, M., de Blas, P. A., Arnalich, F., Pérez, V. E., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06821-1 · Cited by 73
Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic
Matthay, M. A., & Hendrickson, C. M. (2013) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0033-1351122 · Cited by 71
Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study
Loubet, P., Voiriot, G., Houhou‐Fidouh, N., Neuville, M., Bouadma, L., Lescure, F.-X., Descamps, D., Timsit, J., Yazdanpanah, Y., & Visseaux, B. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.04.001 · Cited by 69
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis
PASCALE, G. D., Maio, F. D., Carelli, S., Angelis, G. D., Cacaci, M., Montini, L. M., Bello, G., Cutuli, S. L., Pintaudi, G., Tanzarella, E. S., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03623-4 · Cited by 70
Relationship between nasopharyngeal microbiota and patient’s susceptibility to viral infection
Dubourg, G., Edouard, S., & Raoult, D. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1621168 · Cited by 66
Postviral Complications
Prasso, J. E., & Deng, J. C. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.11.006 · Cited by 67
Host physiologic changes induced by influenza a virus lead to staphylococcus aureus biofilm dispersion and transition from asymptomatic colonization to invasive disease
Reddinger, R. M., Luke-Marshall, N. R., Hakansson, A. P., & Campagnari, A. A. (2016) · mBio · doi:10.1128/mbio.01235-16 · Cited by 62
Bacterial pneumonia as an influenza complication
Martín‐Loeches, I., Gréve, F. V. S., & Schultz, M. J. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000347 · Cited by 59
Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study
Santis, V. D., Corona, A., Vitale, D., Nencini, C., Potalivo, A., Prete, A., Zani, G., Malfatto, A., Tritapepe, L., Taddei, S., et al. (2021) · Infection · doi:10.1007/s15010-021-01661-2 · Cited by 58
Multi-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19
Pasero, D., Cossu, A. P., & Terragni, P. (2021) · Microorganisms · doi:10.3390/microorganisms9081773 · Cited by 60
Clinical characteristics of children and adults hospitalized for influenza virus infection
Leung, C.-H., Tseng, H.-K., Wang, W., Chiang, H.-T., Wu, A. Y.-J., & Liu, C.-P. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.06.002 · Cited by 56
Recognition of Viral RNA by Pattern Recognition Receptors in the Induction of Innate Immunity and Excessive Inflammation During Respiratory Viral Infections
Okamoto, M., Tsukamoto, H., Kouwaki, T., Seya, T., & Oshiumi, H. (2017) · Viral Immunology · doi:10.1089/vim.2016.0178 · Cited by 58
Influenza-associated aspergillosis in critically-ill patients—a retrospective bicentric cohort study
Waldeck, F., Boroli, F., Suh, N., Wendel‐Garcia, P. D., Flury, D., Notter, J., Iten, A., Kaiser, L., Schrenzel, J., Boggian, K., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03923-7 · Cited by 55
Secondary bacterial infections and antimicrobial resistance in COVID-19: comparative evaluation of pre-pandemic and pandemic-era, a retrospective single center study
Karataş, M., Yaşar, M., Tünger, A., Çilli, F., Aydemir, Ş., & Özenci, V. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00454-7 · Cited by 55
Protecting Against Post-influenza Bacterial Pneumonia by Increasing Phagocyte Recruitment and ROS Production
Subramaniam, R., Barnes, P. F., Fletcher, K., Boggaram, V., Hillberry, Z., Neuenschwander, P. F., & Shams, H. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit830 · Cited by 55
Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults
Crotty, M. P., Meyers, S., Hampton, N. B., Bledsoe, S., Ritchie, D. J., Buller, R. S., Storch, G. A., Micek, S. T., & Kollef, M. H. (2015) · Medicine · doi:10.1097/md.0000000000002332 · Cited by 55
Severe influenza: overview in critically ill patients
Sarda, C., Palma, P., & Rello, J. (2019) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000638 · Cited by 56
Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children With Influenza-related Critical Illness
Randolph, A. G., Xu, R., Novak, T., Newhams, M. M., Wardenburg, J. B., Weiss, S. L., Sanders, R. C., Thomas, N. J., Hall, M. W., Tarquinio, K. M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy495 · Cited by 54
Self-citation
Recent advances in our understanding of Streptococcus pneumoniae infection
Feldman, C. H., & Anderson, R. (2014) · F1000Prime Reports · doi:10.12703/p6-82 · Cited by 52
Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection
Robinson, K. M., Ramanan, K., Clay, M. E., McHugh, K. J., Rich, H. E. A., & Alcorn, J. F. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.32 · Cited by 51
Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis
Arranz-Herrero, J., Presa, J., Rius‐Rocabert, S., Utrero‐Rico, A., Arranz-Arija, J. Á., Lalueza, A., Escribese, M. M., Ochando, J., Soriano, V., & Nistal‐Villán, E. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.04.003 · Cited by 51
Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies
Rosado, M. M., Gesualdo, F., Marcellini, V., Sabatino, A. D., Corazza, G. R., Smacchia, M. P., Nobili, B., Baronci, C., Russo, L., Rossi, F., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201343577 · Cited by 50
Clinical characteristics and outcomes of severe rhinovirus-associated pneumonia identified by bronchoscopic bronchoalveolar lavage in adults: Comparison with severe influenza virus-associated pneumonia
Choi, S., Huh, J. W., Hong, S., Lee, J. Y., Kim, S., Sung, H., Do, K., Lee, S., Kim, M., Jeong, J., et al. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.11.010 · Cited by 50
IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections
Shepardson, K. M., Larson, K., Johns, L. L., Stanek, K., Cho, H., Wellham, J., Henderson, H., & Rynda‐Apple, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02589 · Cited by 47
The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19)
Henry, B. M., Benoit, S. W., Vikse, J., Berger, B. A., Pulvino, C., Hoehn, J. M., Rose, J., de Oliveira, M. H. S., Lippi, G., & Benoit, J. L. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1284 · Cited by 50
Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions
Bahçe, Y. G., Acer, Ö., & Özüdoğru, O. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105409 · Cited by 52
Bacterial coinfection in influenza pneumonia: Rates, pathogens, and outcomes
Bartley, P., Deshpande, A., Yu, P.-C., Klompas, M., Haessler, S., Imrey, P. B., Zilberberg, M. D., & Rothberg, M. B. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.96 · Cited by 51
The influenza-injured lung microenvironment promotes MRSA virulence, contributing to severe secondary bacterial pneumonia
Langouët-Astrié, C. J., Oshima, K., McMurtry, S. A., Yang, Y., Kwiecinski, J. M., LaRivière, W. B., Kavanaugh, J. S., Zakharevich, I., Hansen, K. C., Shi, D., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111721 · Cited by 49
Coinfection with SARS‐CoV‐2 and other respiratory pathogens in patients with COVID‐19 in Guangzhou, China
Li, Z., Chen, Z., Chen, L., Zhan, Y., Li, S., Cheng, J., Zhu, A., Chen, L., Zhong, N., Li, S.-Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26073 · Cited by 48
Community-acquired pneumonia
Remington, L. T., & Sligl, W. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000052 · Cited by 48
Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients
Teng, F., Liu, X., Guo, S., Li, Z. Y., Ji, W., Zhang, F., & Zhu, X. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.10.014 · Cited by 48
Analysis of the clinical characteristics of 77 COVID-19 deaths
Wang, K., Qiu, Z., Liu, J., Fan, T. T., Liu, C., Tian, P., Wang, Y., Ni, Z., Zhang, S., Luo, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73136-7 · Cited by 47
IL-22-binding protein exacerbates influenza, bacterial super-infection
Abood, R. N., McHugh, K. J., Rich, H. E. A., Ortiz, M. A., Tobin, J. M., Ramanan, K., Robinson, K. M., Bomberger, J. M., Kolls, J. K., Manni, M. L., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0188-7 · Cited by 51
Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function
Yang, Z., Chiou, T. T.-Y., Stossel, T. P., & Kobzik, L. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00094.2015 · Cited by 44
Polymicrobial community‐acquired pneumonia: An emerging entity
Cillóniz, C., Čivljak, R., Nicolini, A., & Torres, A. (2015) · Respirology · doi:10.1111/resp.12663 · Cited by 46
Global Variability in Reported Mortality for Critical Illness during the 2009-10 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Regression to Guide Reporting of Outcomes during Disease Outbreaks
Duggal, A., Pinto, R. L., Rubenfeld, G. D., & Fowler, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155044 · Cited by 44
Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients
Carbonell, R., Urgelés, S., Salgado, M., Rodríguez, A. H., Reyes, L. F., Fuentes, Y. V., Serrano-Mayorga, C. C., Cáceres, E. L., Bodí, M. A., Martín‐Loeches, I., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.06.024 · Cited by 42
Identification of Concurrent Bacterial Infection in Adult Patients with Dengue
See, K. C., Phua, J., Yip, H. S., Yeo, L. L. L., & Lim, T. K. (2013) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0197 · Cited by 43
Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief
Ishaqui, A. A., Khan, A. H., Sulaiman, S. A. S., Alsultan, M. T., Khan, I., & Naqvi, A. A. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1730180 · Cited by 41
Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship
Crotty, M. P., Meyers, S., Hampton, N. B., Bledsoe, S., Ritchie, D. J., Buller, R. S., Storch, G. A., Kollef, M. H., & Micek, S. T. (2015) · Critical Care · doi:10.1186/s13054-015-1120-5 · Cited by 43

Authors: Rice, T. W., Rubinson, L., Uyeki, T. M., Vaughn, F. L., John, B. B., Miller, R. R., Higgs, E., Randolph, A. G., Smoot, B. E., & Thompson, B. T.
Affiliations: Vanderbilt University (US)
Centers for Disease Control and Prevention (US)
University of Utah (US)
National Institutes of Health (US)
Boston Children's Hospital (US)
Harvard University (US)
ORCID: Rice, Todd W.
Uyeki, Timothy M.
Randolph, Adrienne G.
Thompson, B. Taylor
Venue: Critical Care Medicine
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2012-05
Volume: 40
Issue: 5
Pages: 1487-1498
ISSN: 0090-3493 (ISSN-L)
DOI: 10.1097/ccm.0b013e3182416f23
PMC: PMC3653183
OpenAlex: W1995615618
Cited by: 391
References: 37
Citations by year: 2026: 12 · 2025: 23 · 2024: 30 · 2023: 30 · 2022: 51 · 2021: 60 · 2020: 48 · 2019: 20 · 2018: 21 · 2017: 20 · 2016: 17 · 2015: 13 · 2014: 15 · 2013: 24 · 2012: 7
FWCI: 14.13
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Critical Care Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (n01hr56174-20-0-1, n01hr56179-17-0-1)
National Heart, Lung, and Blood Institute (N01 HR 56179, K23HL081431, N01 HR056179, N01 HR056174)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: bacterial co-infection, critical illness, ICU mortality, Staphylococcus aureus, Streptococcus pneumoniae, bacteremia, bacterial pneumonia, shock, mechanical ventilation, comorbidities, ICU length of stay, mortality risk factors, hospitalized adults
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Bacterial Infections, Female, Humans, Influenza, Human, Intensive Care Units, Male, Middle Aged, Prospective Studies, Retrospective Studies, United States, Chi-Square Distribution, Critical Illness, Statistics, Nonparametric, Influenza A Virus, H1N1 Subtype, Young Adult, Pandemics, Coinfection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks